Sequencing of treatment matters in synchronous liver or lung only metastatic colon cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.4049
Abstract: 4049Background: Per SEER database, approximately 21% of patients have synchronous metastatic disease at presentation with a median 5 year survival of 14%. Liver is by far the most common site of me... read more here.
Keywords: synchronous liver; sequencing treatment; matters synchronous; lung metastatic ... See more keywords